Condition: GERD in Children · Cystic Fibrosis in Children · Sponsor: Duke University
The purpose of this study is to evaluate the prevalence of gastroesophageal reflux disease (GERD) symptoms in pediatric patients with cystic fibrosis using the Gastroesophageal Symptom Assessment Scale (GSAS) and the impact of stopping anti-GERD therapy on the GERD symptoms reported.
This description comes directly from the study's public registry record.
Yara Salameh, MF · 919-684-8111 · yara.salameh@duke.edu
Shatha Yousef, MD · shatha.yousef@duke.edu
Always discuss trial participation with your own doctor first.
| Duke University Hospital | Durham, North Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06617013